Medical Progress Today
mpt home | sign up

Volume 5, Number 9
March 28, 2008


PRINTER FRIENDLY

In the Spotlight

Conflicted doctors

Peter Huber, Forbes, 4-7-08

Brilliant doctors often work closely with big drug companies, and they seem to like their corporate partners just fine. Too fine, say their vocal critics—no doctor can have objective views about Lipitor when he takes Pfizer's money to develop or test it. But when the critics are doctors themselves, as they quite often are, keep in mind that there's a deeper conflict in play here that the critics never acknowledge or discuss. By working at the cutting edge of pharmacology in close collaboration with Big Pharma, top–tier doctors are taking over the whole medical show. It's because of their work that so many of their less able colleagues are destined to provide doc–in–a–box services at Wal–Mart, at cut–rate prices prescribed by Big Insurance or Big Government.
Continue reading . . .


News

· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


Commentary

· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


Research

· Why States Are So Miffed about Medicaid — Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>



Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

NEW SECOND OPINION!
Should drug companies inform doctors about off-label uses of their products?

This Week's Expert Panel:   • Richard Epstein
  • Paul Howard
  • Gilbert Ross
  • Thomas Stossel
  • Benjamin Zycher

Click here to read their second opinions.


SPOTLIGHT

Conflicted doctors

New Report by Tarren Bragdon
Rx NY: A Prescription for More Accessible Health Care in NY

New book by Regina Herzlinger: Who Killed Health Care: America's $2 Trillion Problem - and the Consumer-Driven Cure (McGraw-Hill, June 2007)

Advanced copies available now at Amazon

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org